Literature DB >> 25840911

Macrophage epoxygenase determines a profibrotic transcriptome signature.

Ana Garcia Diaz1, Lara Venda1, Jeong-Hun Ko2, Jacques Behmoaras2, Prashant Srivastava3, Alex Montoya4, Peter Faull4, Zoe Webster5, Ben Moyon5, Charles D Pusey6, David J Abraham7, Enrico Petretto3, Terence H Cook2, Timothy J Aitman1,8.   

Abstract

Epoxygenases belong to the cytochrome P450 family. They generate epoxyeicosatrienoic acids, which are known to have anti-inflammatory effects, but little is known about their role in macrophage function. By high-throughput sequencing of RNA in primary macrophages derived from rodents and humans, we establish the relative expression of epoxygenases in these cells. Zinc-finger nuclease-mediated targeted gene deletion of the major rat macrophage epoxygenase Cyp2j4 (ortholog of human CYP2J2) resulted in reduced epoxyeicosatrienoic acid synthesis. Cyp2j4(-/-) macrophages have relatively increased peroxisome proliferator-activated receptor-γ levels and show a profibrotic transcriptome, displaying overexpression of a specific subset of genes (260 transcripts) primarily involved in extracellular matrix, with fibronectin being the most abundantly expressed transcript. Fibronectin expression is under the control of epoxygenase activity in human and rat primary macrophages. In keeping with the in vitro findings, Cyp2j4(-/-) rats show upregulation of type I collagen following unilateral ureter obstruction of the kidney, and quantitative proteomics analysis (liquid chromatography-tandem mass spectrometry) showed increased renal type I collagen and fibronectin protein abundance resulting from experimentally induced crescentic glomerulonephritis in these rats. Taken together, these results identify the rat epoxygenase Cyp2j4 as a determinant of a profibrotic macrophage transcriptome that could have implications in various inflammatory conditions, depending on macrophage function.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25840911      PMCID: PMC4417646          DOI: 10.4049/jimmunol.1402979

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway.

Authors:  Evan D Rosen; Chung-Hsin Hsu; Xinzhong Wang; Shuichi Sakai; Mason W Freeman; Frank J Gonzalez; Bruce M Spiegelman
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

Review 2.  Leukotrienes.

Authors:  Marc Peters-Golden; William R Henderson
Journal:  N Engl J Med       Date:  2007-11-01       Impact factor: 91.245

3.  Cytochrome P450-dependent arachidonic acid metabolism in human kidney.

Authors:  M L Schwartzman; P Martasek; A R Rios; R D Levere; K Solangi; A I Goodman; N G Abraham
Journal:  Kidney Int       Date:  1990-01       Impact factor: 10.612

Review 4.  Epoxides and soluble epoxide hydrolase in cardiovascular physiology.

Authors:  John D Imig
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

5.  Expression of the cytochrome P450 epoxygenase CYP2J2 in human monocytic leukocytes.

Authors:  Kaeko Nakayama; Takeaki Nitto; Teruo Inoue; Koichi Node
Journal:  Life Sci       Date:  2008-07-12       Impact factor: 5.037

Review 6.  The pharmacology of the cytochrome P450 epoxygenase/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease.

Authors:  Ingrid Fleming
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

7.  Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases.

Authors:  S I Rennard; G W Hunninghake; P B Bitterman; R G Crystal
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

Review 8.  Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases.

Authors:  John D Imig; Bruce D Hammock
Journal:  Nat Rev Drug Discov       Date:  2009-10       Impact factor: 84.694

9.  Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia.

Authors:  Karni S Moshal; Darryl C Zeldin; Srinivas D Sithu; Utpal Sen; Neetu Tyagi; Munish Kumar; William M Hughes; Naira Metreveli; Dorothea S E Rosenberger; Mahavir Singh; Thomas P Vacek; Walter E Rodriguez; Adeagbo Ayotunde; Suresh C Tyagi
Journal:  J Cell Physiol       Date:  2008-06       Impact factor: 6.384

Review 10.  The M1 and M2 paradigm of macrophage activation: time for reassessment.

Authors:  Fernando O Martinez; Siamon Gordon
Journal:  F1000Prime Rep       Date:  2014-03-03
View more
  13 in total

1.  Epoxy Fatty Acids: From Salt Regulation to Kidney and Cardiovascular Therapeutics: 2019 Lewis K. Dahl Memorial Lecture.

Authors:  John D Imig; Wojciech K Jankiewicz; Abdul H Khan
Journal:  Hypertension       Date:  2020-06-01       Impact factor: 10.190

Review 2.  Rat models of human diseases and related phenotypes: a systematic inventory of the causative genes.

Authors:  Claude Szpirer
Journal:  J Biomed Sci       Date:  2020-08-02       Impact factor: 8.410

3.  Identification of a nutrient-sensing transcriptional network in monocytes by using inbred rat models on a cafeteria diet.

Authors:  Neus Martínez-Micaelo; Noemi González-Abuín; Ximena Terra; Ana Ardévol; Montserrat Pinent; Enrico Petretto; Jacques Behmoaras; Mayte Blay
Journal:  Dis Model Mech       Date:  2016-07-13       Impact factor: 5.758

4.  Identification of Ceruloplasmin as a Gene that Affects Susceptibility to Glomerulonephritis Through Macrophage Function.

Authors:  Tai-Di Chen; Maxime Rotival; Ling-Yin Chiu; Marta Bagnati; Jeong-Hun Ko; Prashant K Srivastava; Enrico Petretto; Charles D Pusey; Ping-Chin Lai; Timothy J Aitman; H Terence Cook; Jacques Behmoaras
Journal:  Genetics       Date:  2017-04-26       Impact factor: 4.562

5.  Mechanism of Chronic Kidney Disease Progression and Novel Biomarkers: A Metabolomic Analysis of Experimental Glomerulonephritis.

Authors:  Kyoung Hee Han; Bora Kim; Sang Chun Ji; Hee Gyung Kang; Hae Il Cheong; Joo-Youn Cho; Il-Soo Ha
Journal:  Metabolites       Date:  2020-04-24

6.  Epoxygenase inactivation exacerbates diet and aging-associated metabolic dysfunction resulting from impaired adipogenesis.

Authors:  Antoni Olona; Ximena Terra; Jeong-Hun Ko; Carme Grau-Bové; Montserrat Pinent; Anna Ardevol; Ana Garcia Diaz; Aida Moreno-Moral; Matthew Edin; David Bishop-Bailey; Darryl C Zeldin; Timothy J Aitman; Enrico Petretto; Mayte Blay; Jacques Behmoaras
Journal:  Mol Metab       Date:  2018-03-09       Impact factor: 7.422

7.  Digital expression explorer 2: a repository of uniformly processed RNA sequencing data.

Authors:  Mark Ziemann; Antony Kaspi; Assam El-Osta
Journal:  Gigascience       Date:  2019-04-01       Impact factor: 6.524

8.  New Wistar Kyoto and spontaneously hypertensive rat transgenic models with ubiquitous expression of green fluorescent protein.

Authors:  Ana Isabel Garcia Diaz; Ben Moyon; Philip M Coan; Neza Alfazema; Lara Venda; Kevin Woollard; Tim Aitman
Journal:  Dis Model Mech       Date:  2016-01-14       Impact factor: 5.758

9.  Tracing tumorigenesis in a solid tumor model at single-cell resolution.

Authors:  Samantha D Praktiknjo; Benedikt Obermayer; Qionghua Zhu; Liang Fang; Haiyue Liu; Hazel Quinn; Marlon Stoeckius; Christine Kocks; Walter Birchmeier; Nikolaus Rajewsky
Journal:  Nat Commun       Date:  2020-02-20       Impact factor: 14.919

10.  CYP450-derived oxylipins mediate inflammatory resolution.

Authors:  Derek W Gilroy; Matthew L Edin; Roel P H De Maeyer; Jonas Bystrom; Justine Newson; Fred B Lih; Melanie Stables; Darryl C Zeldin; David Bishop-Bailey
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.